Minna Luo

1.0k total citations
28 papers, 723 citations indexed

About

Minna Luo is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Minna Luo has authored 28 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Minna Luo's work include Cancer Cells and Metastasis (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer-related Molecular Pathways (3 papers). Minna Luo is often cited by papers focused on Cancer Cells and Metastasis (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer-related Molecular Pathways (3 papers). Minna Luo collaborates with scholars based in China and United States. Minna Luo's co-authors include Shan Shao, Shangke Huang, Xinhan Zhao, Shanzhi Gu, Xiaoxiao Zuo, Xiaojin Zhang, Meng Du, Xinhan Zhao, Ying Wang and Caigang Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The FASEB Journal.

In The Last Decade

Minna Luo

27 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minna Luo China 12 465 314 233 87 67 28 723
Shangke Huang China 13 421 0.9× 274 0.9× 244 1.0× 110 1.3× 69 1.0× 28 743
Monish Ram Makena United States 13 562 1.2× 295 0.9× 196 0.8× 86 1.0× 63 0.9× 27 839
Shucai Yang China 13 509 1.1× 230 0.7× 317 1.4× 154 1.8× 95 1.4× 24 793
Taiji Yamazoe Japan 13 546 1.2× 437 1.4× 231 1.0× 125 1.4× 63 0.9× 26 1.0k
Gyu-Beom Jang South Korea 10 595 1.3× 351 1.1× 179 0.8× 71 0.8× 76 1.1× 12 819
Xianhui Ruan China 16 647 1.4× 262 0.8× 332 1.4× 101 1.2× 138 2.1× 63 982
Lijun Zhao China 15 430 0.9× 167 0.5× 310 1.3× 88 1.0× 55 0.8× 49 755
Amar Desai United States 11 386 0.8× 185 0.6× 157 0.7× 76 0.9× 52 0.8× 23 599
Beatriz Soldevilla Spain 15 523 1.1× 389 1.2× 295 1.3× 200 2.3× 75 1.1× 25 918
Liang Hao China 15 494 1.1× 207 0.7× 211 0.9× 81 0.9× 68 1.0× 37 734

Countries citing papers authored by Minna Luo

Since Specialization
Citations

This map shows the geographic impact of Minna Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minna Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minna Luo more than expected).

Fields of papers citing papers by Minna Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minna Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minna Luo. The network helps show where Minna Luo may publish in the future.

Co-authorship network of co-authors of Minna Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Minna Luo. A scholar is included among the top collaborators of Minna Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minna Luo. Minna Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Sijia, Na Zhao, Meng Liu, et al.. (2025). Global burden of leishmaniasis, 1990–2021: systematic analysis of the global burden of disease study. International Journal for Equity in Health. 24(1). 329–329.
2.
Wang, Lu, Lifen Zhang, Shan Shao, et al.. (2024). GAPVD1 Promotes the Proliferation of Triple-negative Breast Cancer Cells by Regulating the ERK/MAPK Signaling Pathway. Current Cancer Drug Targets. 25(5). 509–519. 1 indexed citations
3.
Liu, Yi, Xiaoning Wang, Hui Feng, et al.. (2024). Glutathione-depleting Liposome Adjuvant for Augmenting the Efficacy of a Glutathione Covalent Inhibitor Oridonin for Acute Myeloid Leukemia Therapy. Journal of Nanobiotechnology. 22(1). 299–299. 7 indexed citations
4.
Wang, Lu, Lifen Zhang, Lin Zhao, et al.. (2023). VEGFA/NRP-1/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk. International Journal of Biological Sciences. 20(2). 446–463. 34 indexed citations
5.
Wang, Xiaoning, Jie Wang, Guoqing Li, et al.. (2023). The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients. Frontiers in Medicine. 10. 1165445–1165445. 3 indexed citations
6.
Zhao, Lin, Yujiao Zhang, Shan Shao, et al.. (2023). Comprehensive Analysis of the Expression and Prognosis of chromobox Family Members in Breast Cancer. Clinical Breast Cancer. 23(4). e206–e218. 3 indexed citations
7.
Zhang, Dong, Lin Zhao, Minna Luo, Jianjun Lei, & Shan Shao. (2021). Yap-Myc signaling induces pancreatic stellate cell activation through regulating glutaminolysis. Experimental Cell Research. 411(1). 113000–113000. 9 indexed citations
8.
9.
Shao, Shan, Lin Zhao, Lingxiao Zhang, et al.. (2020). Metformin suppresses HIF‐1α expression in cancer‐associated fibroblasts to prevent tumor‐stromal cross talk in breast cancer. The FASEB Journal. 34(8). 10860–10870. 34 indexed citations
10.
Jiang, Tao, et al.. (2019). The anthelmintic drug flubendazole induces cell apoptosis and inhibits NF-κB signaling in esophageal squamous cell carcinoma. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Chen, Shiyi, Minna Luo, Lian Ma, & Lin Wang. (2018). Ethylacetate extract from Tetrastigma hemsleyanum inhibits proliferation and induces apoptosis in HepG2 and SMMC-7721 cells. SHILAP Revista de lepidopterología. 2 indexed citations
12.
Du, Meng, Min Meng, Anqi Luo, et al.. (2018). Effects of VEGFR1+ hematopoietic progenitor cells on pre-metastatic niche formation and in vivo metastasis of breast cancer cells. Journal of Cancer Research and Clinical Oncology. 145(2). 411–427. 34 indexed citations
13.
Du, Meng, Qiongfang Yu, Feng Lu, et al.. (2018). Citron kinase (CIT-K) promotes aggressiveness and tumorigenesis of breast cancer cells in vitro and in vivo: preliminary study of the underlying mechanism. Clinical & Translational Oncology. 21(7). 910–923. 12 indexed citations
14.
Huang, Shangke, Na Yuan, Guanying Wang, et al.. (2018). Cellular communication promotes mammosphere growth and collective invasion through microtubule‑like structures and angiogenesis. Oncology Reports. 40(6). 3297–3312. 6 indexed citations
15.
Liu, Tong, Hao Zhang, Li Sun, et al.. (2017). FSIP1 binds HER2 directly to regulate breast cancer growth and invasiveness. Proceedings of the National Academy of Sciences. 114(29). 7683–7688. 25 indexed citations
16.
Luo, Minna, Lei Hou, Jian Li, et al.. (2016). VEGF/NRP-1 axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin. Cancer Letters. 373(1). 1–11. 127 indexed citations
17.
Zhang, Hao, Minna Luo, Zining Jin, et al.. (2015). Expression and clinicopathological significance of FSIP1 in breast cancer. Oncotarget. 6(12). 10658–10666. 21 indexed citations
18.
Zhang, Zhe, Lei Hou, Feng Lu, et al.. (2015). An antimicrobial peptide containing NGR motif has potent antitumor activity against CD13+ and CD13− tumor cells. Tumor Biology. 36(10). 8167–8175. 3 indexed citations
19.
Shao, Shan, Xiaojin Zhang, Minna Luo, et al.. (2015). Notch1 signaling regulates the epithelial–mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Molecular Cancer. 14(1). 28–28. 176 indexed citations
20.
Wang, Dan, Ping Lu, Hao Zhang, et al.. (2014). Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients. Oncotarget. 5(21). 10803–10815. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shangke Huang Breakdown of academic impact, for papers by Monish Ram Makena Breakdown of academic impact, for papers by Shucai Yang Breakdown of academic impact, for papers by Taiji Yamazoe Breakdown of academic impact, for papers by Gyu-Beom Jang Breakdown of academic impact, for papers by Xianhui Ruan Breakdown of academic impact, for papers by Lijun Zhao Breakdown of academic impact, for papers by Amar Desai Breakdown of academic impact, for papers by Beatriz Soldevilla Breakdown of academic impact, for papers by Liang Hao
Rankless by CCL
2026